WELCOME TO mediVR®
The Future Of Rehabilitation
Heal Better Recover Faster Regain Mobility with mediVR®
mediVR® uses SCCT therapy to enhance cognitive function and treat physical disorders through innovative VR rehabilitation therapy.
Available for Limited Time Only!





2000+ Active Patients

TRUSTED BY LEADING INSTITUTES







Healing Journeys
“mediVR® gave me a second life.” – Mark Alvin, Dubai UAE
Stroke Recovery
mediVR® helped stroke survivor Mark Alvin regain speech and independence, giving him a new lease on life after 16 sessions.
Cerebral Palsy
13-year-old boy suffering from Cerebral Palsy walked for the first time in his life after just 24 rehabilitation sessions, inspiring many.
“mediVR fulfilled my dream of walking” – Kamagome Haruto, Japan
Spinal Recovery
18-year-old Ohashi Masahiro made a remarkable recovery after spinal cord infarction, overcoming significant challenges.
ASD/ADHD
4-year-old Sakura Tanaka, diagnosed with ASD, gained independence through MediVR. After sessions, she can play a ball game on her own and is more settled in class. 8 months later, she no longer leaves her seat during class.
“She is much more settled & calm in class.” – Sakura’s Teacher
ABOUT US
Why Choose Our VR-Powered Physiotherapy?
mediVR® is a cutting-edge Japanese Technology dedicated to revolutionizing the healthcare industry through immersive Virtual Reality solutions offering:
- Faster Recovery Times
- Personalized Therapy Sessions
- Advanced VR-Based Treatment
- Free Initial Trial – No Commitment!
mediVR® is an Osaka University venture, established in 2016 through an industrial-academic collaboration. With over 25 intellectual properties and FDA-approved licenses in Japan, mediVR® continues to innovate in rehabilitation technology.
Groundbreaking Medical Innovation

Founded in 2016 as a result of groundbreaking research conducted by the faculty of Osaka University, Japan

From Japan

Trusted by 120+ Healthcare Facilities in Japan

To UAE

Exclusively Available in UAE via MCOI Group

The Future Of Rehab


Features
Advanced Features for Enhanced Medical Precision
01. Multisensory Biofeedback System
Utilizes multiple sensory inputs to provide real-time feedback, enhancing patient awareness and promoting better engagement for improved rehabilitation outcomes.
02. Risk Free Rehabilitation Process
Offers a safe, controlled environment for rehabilitation, minimizing risks while maximizing therapeutic benefits for patients during their recovery journey.
03. Immersive 3d Environment Treatment
Employs an interactive, immersive 3D virtual environment to simulate real-world scenarios, promoting effective rehabilitation and improving motor and cognitive skills.
04. Precise Control of the Interactive Process
Ensures accurate control over rehabilitation exercises, tailoring the process to each patient's needs and ensuring optimal results throughout their recovery.
Why mediVR®?
Discover why mediVR® is known as the future of rehab

Specialized Treatment for Neurological, Orthopedic, and Pediatric Conditions
mediVR® offers advanced care for stroke, Parkinson’s, cerebral ataxia, cerebral palsy, spinal cord injuries, autism, ASD, ADHD, and chronic pain, with personalized treatment plans from experts in neurology, orthopedics, and pediatrics.
Trusted by Over 120 Healthcare Facilities Worldwide
mediVR® is trusted by more than 120 healthcare facilities globally, including leading institutions in Japan & UAE. Our innovative solutions have earned the confidence of medical professionals and institutions, providing cutting-edge care and improving patient outcomes across the world.


Over 100 Published Case Studies and Scientific Studies
mediVR® is backed by over 100 published case studies and scientific research, showcasing the effectiveness of our innovative treatments. These studies provide strong evidence for the positive impact of our solutions, supporting their credibility and widespread adoption in the healthcare community.
SCIENCE BEHIND THE TREATMENT
Exploring SCCT

SCCT (Somato-Cognitive Coordination Therapy) utilizes virtual reality to enhance physical and cognitive function. By focusing on the interaction between body awareness and cognition, SCCT improves movement and attention. With clinical applications across neurological, orthopedic, and pediatric disorders, it is designed to visualize and resolve somato-cognitive action network (SCAN) dysfunction, offering personalized, effective rehabilitation based on patient needs.
Patents Worldwide
Active Patients
Facilities Worldwide
Positive Reviews
EXCLUSIVE DISTRIBUTOR
About MCO International

MCOI is the exclusive distributor of mediVR® in the MENA region, bringing innovative Japanese medical technology to enhance rehabilitation. Through a successful partnership with over 120 medical facilities in Japan, mediVR® developed immersive VR therapy tools, including SomatoCognitive Coordination Therapy (SCCT), to accelerate patient recovery. This exclusive agreement enables MCOI to introduce advanced healthcare solutions to MENA, transforming rehabilitation practices.
OUR TEAM
AS FEATURED IN
Meet Our Team





BLOG & NEWS
Blog and Articles From mediVR®
List of all 22 Patents held by mediVR
Our Patents Home Services Our Patents Global Patent List 01. Patent No. 6200615 Technology…
Dr. Masahiko Hara – Interview with Forbes
Dr. Masahiko Hara – Awards & Interviews essjay379 / December 4, 2024 / Dr…
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start…
FAQs
Frequently Asked Questions
There are no reported side effects for SCCT Treatment utilized by mediVR®
mediVR® treats 13+ conditions, including developmental, neurological and postoperative rehabilitation
Patients typically spend about 30 minutes in VR rehab during each session.
The average utilization rate of mediVR® is 65-70%
mediVR® holds more than 22 patents, including those from Japan, the USA and China.
mediVR® is exclusively represented by MCOI in UAE & MENA region. You can click here to request an appointment or alternatively visit their office in Dubai.
Contact us now to book your session





2000+ Active Patients